Skip to search.
 BSE 0.00% NSE Down0.62%

Horizon Pharma, Inc. (HZNP)

-NasdaqGM

2.32 Up 0.07(3.11%) 1:30AM

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31-Dec-201231-Dec-201131-Dec-2010
Total Revenue 19,632   6,927   2,376  
Cost of Revenue12,663  7,267  4,263  
Gross Profit 6,969   (340) (1,887)
Operating Expenses
Research Development16,837  15,358  17,697  
Selling General and Administrative69,005  35,322  24,170  
Non Recurring -  69,621   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (78,873) (120,641) (43,754)
Income from Continuing Operations
Total Other Income/Expenses Net433  (1,023)19,053  
Earnings Before Interest And Taxes(78,440)(121,664)(24,701)
Interest Expense14,525  6,284  3,024  
Income Before Tax(92,965)(127,948)(27,725)
Income Tax Expense(5,171)(14,683)(660)
Minority Interest -   -   -  
Net Income From Continuing Ops(87,794)(113,265)(27,065)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (87,794) (113,265) (27,065)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (87,794) (113,265) (27,065)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.